Intratumoral Injection of mRNA-2752 and Pembrolizumab for High-Risk Ductal Carcinoma In Situ
2025 · JAMA Oncology · 14 citations
https://doi.org/10.1001/jamaoncol.2024.5927
K
Kirithiga Ramalingam
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
26
Papers
105
Citations
6
h-index
4
i10-index
Kirithiga Ramalingam is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Genomics and Diagnostics & Cancer Immunotherapy and Biomarkers. The author has an h-index of 6, co-authored 23 publications.
ORCID: 0000-0002-1774-6891Papers by this author
worksMedicaid Expansion and Overall Survival of Lower Gastrointestinal Cancer Patients After Cytoreductive Surgery and Heated Intraperitoneal Chemotherapy
2024 · Annals of Surgical Oncology · 3 citations
https://doi.org/10.1245/s10434-024-16446-8
Awareness and utilization of genetic testing for hereditary cancers in cancer survivors: a cross-sectional 2021 HINTS-SEER study
2025 · Journal of Cancer Survivorship · 0 citations
https://doi.org/10.1007/s11764-025-01823-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat